Results 191 to 200 of about 7,735 (257)

Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial. [PDF]

ESMO Open
Scanlon E, Lavery A, Albraikat M, Stevenson L, Kennedy C, Byrne R, Walker A, Mullan-Young B, McManus DT, Virdee PS, Elhussein L, Turbitt J, Collinson D, Miedzybrodzka Z, Van Schaeybroeck S, McQuaid S, James JA, Craig SG, Blayney JK, Petty RD, Harkin DP, Kennedy RD, Eatock MM, Middleton MR, Thomas A, Turkington RC.   +25 more
europepmc   +1 more source

Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110). [PDF]

ESMO Open
Boukovala M, Modest DP, Ricard I, Fischer von Weikersthal L, Decker T, Vehling-Kaiser U, Uhlig J, Schenk M, Freiberg-Richter J, Peuser B, Denzlinger C, Peveling Genannt Reddemann C, Graeven U, Schuch G, Schwaner I, Heinrich K, Neumann J, Jung A, Held S, Stintzing S, Heinemann V, Michl M.   +21 more
europepmc   +1 more source

Neuroprotective effect of pyruvate and oxaloacetate during pilocarpine induced status epilepticus in rats

, 2010
Andrezza Sossai Rodrigues de Carvalho, Laila Brito Torres, Daniele Suzete Persike, Maria José da Silva Fernandes, Débora Amado, Maria da Graça Naffah‐Mazzacoratti, Ésper A. Cavalheiro, Alexandre Valotta da Silva   +7 more
openalex   +1 more source

Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial. [PDF]

J Clin Oncol
Jia R, Shan T, Zheng A, Zhang Y, Lu P, Zhang G, Wang F, Xu Z, Zheng G, Tang D, Zhang W, Li W, Li R, Guo Y, Liu L, Luo X, Zheng Y, Chang Z, Wang Q, Wang X, Yuan X, Kong G, Li S, Yang R, Zhou D, Ren J, Yin W, Li J, Zhang J, Wang Z, Sheng M, Xu B, Li L, Liu X, Lu Z, Wan L, Zhou F, Gao S.   +37 more
europepmc   +1 more source

Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study. [PDF]

BioDrugs, 2021
Qin S, Li J, Bai Y, Shu Y, Li W, Yin X, Cheng Y, Sun G, Deng Y, Zhong H, Li Y, Qian X, Zhang L, Zhang J, Chen K, Kang W, HLX04-mCRC03 Investigators.   +16 more
europepmc   +1 more source

Effects of Oxaloacetate on cortical evoked potentials and adaptibility in focal ischemia

, 2011
József Toldi
openalex   +1 more source

Kinetic Challenges Facing Oxalate, Malonate, Acetoacetate, and Oxaloacetate Decarboxylases

, 2011
Richard Wolfenden, Charles A. Lewis, Yang Yuan   +2 more
openalex   +2 more sources

Author response: Structural insights into sodium transport by the oxaloacetate decarboxylase sodium pump

, 2020
Xin Xu, Huigang Shi, Xiaowen Gong, Pu Chen, Ying Gao, Xinzheng Zhang, Song Xiang   +6 more
openalex   +1 more source

The PEP-pyruvate-oxaloacetate node as the switch point for carbon flux distribution in bacteria.

FEMS Microbiology Reviews, 2005
U. Sauer, B. Eikmanns
semanticscholar   +1 more source

Pyridoxamine-Oxaloacetic Transaminase of Rat Kidney

Journal of Biological Chemistry, 1964
Helen C. Wu, Merle Mason
openaire   +3 more sources